Related Experiment Video
Updated: Oct 3, 2026

11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Recurrent transitional cell carcinoma in an ileal conduit treated by sandwich chemotherapy and surgical resection
1Division of Urologic Surgery, University of Pittsburgh Medical Center, Pennsylvania.
The Journal of Urology
|August 1, 1993
Abstract:
Recurrent transitional cell carcinoma in a ureteroileal conduit following radical cystectomy is rare. The prognosis for these patients is uniformly poor. We report on a patient with transitional cell carcinoma in an ileal conduit treated by chemotherapy and partial excision of the ileal conduit. He was without evidence of disease 4 1/2 years after completion of therapy.

